• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Sana Biotechnology, Inc. - Common Stock (NQ:SANA)

    3.035 +0.105 (+3.58%)
    Streaming Delayed Price Updated: 2:20 PM EDT, Sep 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Sana Biotechnology, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 Next >
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    News headline image
    SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Top 2 Health Care Stocks That Are Ticking Portfolio Bombs ↗
     
    Via Benzinga
    News headline image
    Sana Biotechnology, Inc. Stockholder News: Robbins LLP Reminds Investors of the Class Action Lawsuit Against SANA
    From Robbins LLP
    Via GlobeNewswire
    News headline image
    ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire
    News headline image
    SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    News headline image
    Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    News headline image
    Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    News headline image
    Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why ↗
    Biotech remains a high-risk, high-reward sector, and this month’s top draws reflect retail’s appetite for stocks with major clinical and regulatory catalysts. 
    Via Stocktwits
    News headline image
    There May Still Be Time to Get in on These 3 Trending Biotechs
    Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025. 
    Via MarketBeat
    Topics ETFs Economy
    News headline image
    Biotech Breakthroughs: Sana Biotechnology (NASDAQ: SANA) Type 1 Diabetes, CS Diagnostics (OTCQB: CSDX) Cancer Therapy – CURR, TPET, PRSO, PNPN.V, EONR – Plus More Stocks Under $2 Inside See Now!
    Via AB Newswire
    Topics Artificial Intelligence
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    News headline image
    Crude Oil Down 1%; US Weekly Jobless Claims Decline ↗
     
    Via Benzinga
    News headline image
    AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday ↗
     
    Via Benzinga
    News headline image
    US Stocks Down; Acuity Brands Posts Weak Revenue ↗
     
    Via Benzinga
    News headline image
    Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why ↗
    Sana Biotechnology's first-in-human study shows UP421 pancreatic islet cells surviving and functioning in type 1 diabetes without immunosuppression. 
    Via Benzinga
    News headline image
    Why Cal-Maine Foods Shares Are Trading Higher By 4%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    News headline image
    Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    News headline image
    Sana Biotechnology to Present at December 2024 Investor Conferences
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    News headline image
    Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗
     
    Via Benzinga
    News headline image
    Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    News headline image
    Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference
    From Sana Biotechnology, Inc
    Via GlobeNewswire
    News headline image
    Casella Waste Systems, SES AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
     
    Via Benzinga
    Topics Artificial Intelligence
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.